Blood Disorder Genetics and Thalassemia Department

Genetic Modifiers and Biomarkers

(Investigators Marios S Phylactides, Petros Kountouris, Coralea Stephanou)
Establishment of CING as the national node for biomarker discovery and development for a translational-focused European Research Infrastructure, with BDGT focus on:

Research of erythroid and globin gene regulation
Identification of novel therapeutic targets for blood disorders
Discovery and development of disease biomarkers

Hematogenetic Diagnostic Research and Services

(Hemoglobinopathy Investigators Thessalia Papasavva, Stephania Byrou; Hematology Investigator Panayiota L Papasavva) Molecular research based on massively parallel sequencing and additional ...

Gene Editing and Therapy

(Investigators Carsten W Lederer, Petros Patsali, Panayiota L Papasavva, Marios Phylactides) Establishment of novel gene therapy approaches for hemoglobinopathies and other hematological diseases, ...

Biomedical and Translational Informatics

(Investigators Petros Kountouris, Coralea Stephanou) Development of patient registries for rare hematological diseases at the national and European level, including: RADeep (see ...

Publications

List of BDGTD publications

Grants Obtained

GenoMed4ALL (Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases) – 101017549, 2021-2024. Funded by H2020-SC1-FA-DTS-2020-1 with the total ...

Awards

Όνομα Οργανισμός Βραβείο Carsten W. Lederer Συνέδριο Ευρωπαϊκού Πανεπιστημίου Κύπρου, Κύπρος, 2019 1ο βραβείο για παρουσίαση αφίσας Κοραλία ...